Somatic Editing of Ldlr With Adeno-Associated Viral-CRISPR Is an Efficient Tool for Atherosclerosis Research

Arteriosclerosis, Thrombosis, and Vascular Biology
Kelsey E JarrettWilliam R Lagor

Abstract

Objective- Atherosclerosis studies in Ldlr knockout mice require breeding to homozygosity and congenic status on C57BL6/J background, a process that is both time and resource intensive. We aimed to develop a new method for generating atherosclerosis through somatic deletion of Ldlr in livers of adult mice. Approach and Results- Overexpression of PCSK9 (proprotein convertase subtilisin/kexin type 9) is currently used to study atherosclerosis, which promotes degradation of LDLR (low-density lipoprotein receptor) in the liver. We sought to determine whether CRISPR/Cas9 (clustered regularly interspaced short palindromic repeats-associated 9) could also be used to generate atherosclerosis through genetic disruption of Ldlr in adult mice. We engineered adeno-associated viral (AAV) vectors expressing Staphylococcus aureus Cas9 and a guide RNA targeting the Ldlr gene (AAV-CRISPR). Both male and female mice received either (1) saline, (2) AAV-CRISPR, or (3) AAV-hPCSK9 (human PCSK9)-D374Y. A fourth group of germline Ldlr-KO mice was included for comparison. Mice were placed on a Western diet and followed for 20 weeks to assess plasma lipids, PCSK9 protein levels, atherosclerosis, and editing efficiency. Disruption of Ldlr with AAV-CRISPR...Continue Reading

References

Nov 15, 1994·Archives of Biochemistry and Biophysics·G C Ness, Z Zhao
Feb 24, 2001·The Journal of Immunology : Official Journal of the American Association of Immunologists·Z X LiuG Dennert
Oct 15, 2005·Arteriosclerosis, Thrombosis, and Vascular Biology·Rossi P NaoumovaAnne K Soutar
Jan 17, 2008·Biochemistry·Daping FanSergio Fazio
Aug 30, 2012·Nature Methods·Caroline A SchneiderKevin W Eliceiri
Jan 5, 2013·Science·Le CongFeng Zhang
Jan 5, 2013·Science·Prashant MaliGeorge M Church
Jan 16, 2013·Molecular Therapy : the Journal of the American Society of Gene Therapy·Masataka SuzukiBrendan Lee
Aug 6, 2013·Methods in Molecular Biology·William R LagorDaniel J Rader
Mar 29, 2014·Circulation Research·Martin Maeng BjørklundJacob Fog Bentzon
Jun 12, 2014·Circulation Research·Qiurong DingKiran Musunuru
Sep 30, 2014·Cell·Randall J PlattFeng Zhang
Oct 25, 2014·Arteriosclerosis, Thrombosis, and Vascular Biology·Marta Roche-MolinaJuan A Bernal
Dec 3, 2014·Molecular Therapy. Nucleic Acids·Thomas J CradickGang Bao
Apr 2, 2015·Nature·F Ann RanFeng Zhang
Feb 20, 2016·Circulation Research·Sylvia T NurnbergDaniel J Rader
Mar 5, 2016·Arteriosclerosis, Thrombosis, and Vascular Biology·Xiao WangKiran Musunuru
Mar 17, 2016·Current Atherosclerosis Reports·Ezim Ajufo, Marina Cuchel
Apr 29, 2016·Circulation Research·Hagai TavoriSergio Fazio
Mar 17, 2017·Scientific Reports·Kelsey E JarrettWilliam R Lagor
May 16, 2017·Laboratory Investigation; a Journal of Technical Methods and Pathology·Sandeep KumarHanjoong Jo
Jul 22, 2017·Circulation Research·Alan DaughertyUNKNOWN American Heart Association Council on Arteriosclerosis, Thrombosis and Vascular Biology; and Council on Basic Cardiovascular
Jul 22, 2017·Arteriosclerosis, Thrombosis, and Vascular Biology·Alan DaughertyUNKNOWN American Heart Association Council on Arteriosclerosis, Thrombosis and Vascular Biology; and Council on Basic Cardiovascular
Jul 29, 2017·Arteriosclerosis, Thrombosis, and Vascular Biology·Alexandra C ChadwickKiran Musunuru
Nov 4, 2017·Progress in Retinal and Eye Research·Marina França DiasYoung Jik Kwon
Dec 7, 2017·The New England Journal of Medicine·Lindsey A GeorgeKatherine A High
Jan 6, 2018·Arteriosclerosis, Thrombosis, and Vascular Biology·Peggy RobinetJonathan D Smith
Feb 13, 2018·Molecular Therapy : the Journal of the American Society of Gene Therapy·Juliette HordeauxJames M Wilson
Feb 28, 2018·Circulation·Alexandra C ChadwickKiran Musunuru
Mar 15, 2018·Nucleic Acids Research·Eva K BrinkmanBas van Steensel
Mar 31, 2018·Molecular Therapy : the Journal of the American Society of Gene Therapy·Kshitiz SinghThierry VandenDriessche

❮ Previous
Next ❯

Citations

Mar 8, 2019·Current Opinion in Lipidology·Ya WangHong S Lu
Dec 24, 2019·Arteriosclerosis, Thrombosis, and Vascular Biology·Hong S LuAlan Daugherty
Feb 20, 2020·Current Opinion in Cardiology·Alexandria M DoerflerWilliam R Lagor
Apr 14, 2020·Expert Opinion on Drug Delivery·Shahin AghamiriHossein Ghanbarian
Mar 28, 2019·Frontiers in Medicine·Eric J MeesterMarion de Jong
May 20, 2020·Nature Communications·Nunzia PastoreAndrea Ballabio
Mar 28, 2019·Arteriosclerosis, Thrombosis, and Vascular Biology·Congqing WuHong S Lu
Mar 21, 2019·Current Opinion in Lipidology·Mia Furgurson, William R Lagor
May 1, 2020·Expert Opinion on Investigational Drugs·Tycho R TrompG Kees Hovingh
Aug 23, 2019·Arteriosclerosis, Thrombosis, and Vascular Biology·Fang LiHanrui Zhang
Jul 28, 2020·Frontiers in Cardiovascular Medicine·Viviana L VedderJeanette Erdmann
Sep 27, 2020·Genes·Ilayda AtesRenee N Cottle
Nov 3, 2020·Frontiers in Cellular Neuroscience·Fan LiAlex W Hewitt
Nov 26, 2020·Molecular Therapy : the Journal of the American Society of Gene Therapy·Garima SharmaChiranjib Chakraborty
Feb 9, 2020·Current Atherosclerosis Reports·Petri MäkinenSeppo Ylä-Herttuala
Feb 13, 2021·Gene Therapy·Dimitrios Laurin WagnerMichael Schmueck-Henneresse
Nov 12, 2020·Frontiers in Genetics·Qianyun GuoYujie Zhou
Feb 21, 2021·Molecular Therapy : the Journal of the American Society of Gene Therapy·Lili WangJames M Wilson
Jun 24, 2020·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Yihan ZhaoDazhuo Shi
Jun 19, 2021·Molecular Therapy. Methods & Clinical Development·Marco De GiorgiWilliam R Lagor
Aug 28, 2021·International Journal of Molecular Sciences·Wei Sheng SiewWei Hsum Yap

❮ Previous
Next ❯

Related Concepts

Related Feeds

CRISPR Ribonucleases Deactivation

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on mechanisms that underlie deactivation of CRISPR ribonucleases. Here is the latest research.

CRISPR (general)

Clustered regularly interspaced short palindromic repeats (CRISPR) are DNA sequences in the genome that are recognized and cleaved by CRISPR-associated proteins (Cas). CRISPR-Cas system enables the editing of genes to create or correct mutations. Discover the latest research on CRISPR here.

CRISPR for Genome Editing

Genome editing technologies enable the editing of genes to create or correct mutations. Clustered regularly interspaced short palindromic repeats (CRISPR) are DNA sequences in the genome that are recognized and cleaved by CRISPR-associated proteins (Cas). Here is the latest research on the use of CRISPR-Cas system in gene editing.

Atherosclerosis Disease Progression

Atherosclerosis is the buildup of plaque on artery walls, causing stenosis which can eventually lead to clinically apparent cardiovascular disease. Find the latest research on atherosclerosis disease progression here.

Biophysics of CRISPR

This feed focuses on broad characteristics of the CRISPR system and the proteins associated with it.

© 2022 Meta ULC. All rights reserved